nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—AKR1C3—Bimatoprost—glaucoma	0.35	0.906	CbGbCtD
Mefenamic acid—Diclofenac—Clonidine—glaucoma	0.281	1	CrCrCtD
Mefenamic acid—PTGS2—glaucoma	0.174	1	CbGaD
Mefenamic acid—CYP2C9—Diclofenamide—glaucoma	0.0129	0.0333	CbGbCtD
Mefenamic acid—CYP2C9—Dorzolamide—glaucoma	0.0124	0.0322	CbGbCtD
Mefenamic acid—CYP2C9—Methazolamide—glaucoma	0.0111	0.0287	CbGbCtD
Mefenamic acid—Acetylsalicylic acid—TP53—glaucoma	0.000619	0.233	CrCbGaD
Mefenamic acid—Floctafenine—PTGS2—glaucoma	0.000318	0.12	CrCbGaD
Mefenamic acid—Tiaprofenic acid—PTGS2—glaucoma	0.000205	0.0772	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS2—glaucoma	0.000205	0.0772	CrCbGaD
Mefenamic acid—Nepafenac—PTGS2—glaucoma	0.000195	0.0734	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—glaucoma	0.000183	0.0688	CrCbGaD
Mefenamic acid—Salsalate—PTGS2—glaucoma	0.000162	0.061	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—glaucoma	0.00016	0.0601	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—glaucoma	0.000134	0.0504	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—PTGS2—glaucoma	0.000121	0.0456	CrCbGaD
Mefenamic acid—Tension—Clonidine—glaucoma	0.000114	0.000972	CcSEcCtD
Mefenamic acid—Insomnia—Dorzolamide—glaucoma	0.000114	0.000969	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Brimonidine—glaucoma	0.000114	0.000968	CcSEcCtD
Mefenamic acid—Anorexia—Pilocarpine—glaucoma	0.000113	0.000965	CcSEcCtD
Mefenamic acid—Feeling abnormal—Acetazolamide—glaucoma	0.000113	0.000963	CcSEcCtD
Mefenamic acid—Nervousness—Clonidine—glaucoma	0.000113	0.000962	CcSEcCtD
Mefenamic acid—Paraesthesia—Dorzolamide—glaucoma	0.000113	0.000962	CcSEcCtD
Mefenamic acid—Dyspnoea—Dorzolamide—glaucoma	0.000112	0.000955	CcSEcCtD
Mefenamic acid—Insomnia—Brinzolamide—glaucoma	0.000112	0.000952	CcSEcCtD
Mefenamic acid—Somnolence—Dorzolamide—glaucoma	0.000112	0.000952	CcSEcCtD
Mefenamic acid—Dyspnoea—Travoprost—glaucoma	0.000112	0.000951	CcSEcCtD
Mefenamic acid—Hypotension—Pilocarpine—glaucoma	0.000111	0.000946	CcSEcCtD
Mefenamic acid—Paraesthesia—Brinzolamide—glaucoma	0.000111	0.000945	CcSEcCtD
Mefenamic acid—Dysuria—Timolol—glaucoma	0.000111	0.000945	CcSEcCtD
Mefenamic acid—Dyspepsia—Dorzolamide—glaucoma	0.000111	0.000943	CcSEcCtD
Mefenamic acid—Dyspnoea—Brinzolamide—glaucoma	0.00011	0.000939	CcSEcCtD
Mefenamic acid—Dyspepsia—Travoprost—glaucoma	0.00011	0.000939	CcSEcCtD
Mefenamic acid—Asthenia—Apraclonidine—glaucoma	0.00011	0.000937	CcSEcCtD
Mefenamic acid—Somnolence—Brinzolamide—glaucoma	0.00011	0.000936	CcSEcCtD
Mefenamic acid—Vision blurred—Clonidine—glaucoma	0.00011	0.000933	CcSEcCtD
Mefenamic acid—Decreased appetite—Dorzolamide—glaucoma	0.000109	0.000931	CcSEcCtD
Mefenamic acid—Urticaria—Acetazolamide—glaucoma	0.000109	0.000928	CcSEcCtD
Mefenamic acid—Tremor—Clonidine—glaucoma	0.000109	0.000928	CcSEcCtD
Mefenamic acid—Dyspepsia—Brinzolamide—glaucoma	0.000109	0.000927	CcSEcCtD
Mefenamic acid—Pruritus—Apraclonidine—glaucoma	0.000109	0.000924	CcSEcCtD
Mefenamic acid—Body temperature increased—Acetazolamide—glaucoma	0.000109	0.000924	CcSEcCtD
Mefenamic acid—Tinnitus—Betaxolol—glaucoma	0.000109	0.000923	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Travoprost—glaucoma	0.000108	0.000921	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Clonidine—glaucoma	0.000108	0.000919	CcSEcCtD
Mefenamic acid—Insomnia—Pilocarpine—glaucoma	0.000108	0.000915	CcSEcCtD
Mefenamic acid—Decreased appetite—Brinzolamide—glaucoma	0.000108	0.000915	CcSEcCtD
Mefenamic acid—Constipation—Travoprost—glaucoma	0.000107	0.000912	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Timolol—glaucoma	0.000107	0.000912	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000107	0.000909	CcSEcCtD
Mefenamic acid—Paraesthesia—Pilocarpine—glaucoma	0.000107	0.000909	CcSEcCtD
Mefenamic acid—Asthenia—Bimatoprost—glaucoma	0.000107	0.000909	CcSEcCtD
Mefenamic acid—Angioedema—Clonidine—glaucoma	0.000106	0.000905	CcSEcCtD
Mefenamic acid—Dyspnoea—Pilocarpine—glaucoma	0.000106	0.000902	CcSEcCtD
Mefenamic acid—Somnolence—Pilocarpine—glaucoma	0.000106	0.0009	CcSEcCtD
Mefenamic acid—Pruritus—Bimatoprost—glaucoma	0.000105	0.000896	CcSEcCtD
Mefenamic acid—Diarrhoea—Apraclonidine—glaucoma	0.000105	0.000894	CcSEcCtD
Mefenamic acid—Malaise—Clonidine—glaucoma	0.000105	0.000893	CcSEcCtD
Mefenamic acid—Dyspepsia—Pilocarpine—glaucoma	0.000105	0.000891	CcSEcCtD
Mefenamic acid—Syncope—Clonidine—glaucoma	0.000104	0.000888	CcSEcCtD
Mefenamic acid—Arrhythmia—Betaxolol—glaucoma	0.000104	0.000885	CcSEcCtD
Mefenamic acid—Feeling abnormal—Dorzolamide—glaucoma	0.000104	0.000883	CcSEcCtD
Mefenamic acid—Decreased appetite—Pilocarpine—glaucoma	0.000103	0.00088	CcSEcCtD
Mefenamic acid—Feeling abnormal—Travoprost—glaucoma	0.000103	0.000879	CcSEcCtD
Mefenamic acid—Conjunctivitis—Timolol—glaucoma	0.000103	0.000876	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Dorzolamide—glaucoma	0.000103	0.000876	CcSEcCtD
Mefenamic acid—Alopecia—Betaxolol—glaucoma	0.000103	0.000875	CcSEcCtD
Mefenamic acid—Palpitations—Clonidine—glaucoma	0.000103	0.000875	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000103	0.000874	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Travoprost—glaucoma	0.000103	0.000872	CcSEcCtD
Mefenamic acid—Loss of consciousness—Clonidine—glaucoma	0.000102	0.00087	CcSEcCtD
Mefenamic acid—Feeling abnormal—Brinzolamide—glaucoma	0.000102	0.000868	CcSEcCtD
Mefenamic acid—Mental disorder—Betaxolol—glaucoma	0.000102	0.000868	CcSEcCtD
Mefenamic acid—Constipation—Pilocarpine—glaucoma	0.000102	0.000865	CcSEcCtD
Mefenamic acid—Dizziness—Apraclonidine—glaucoma	0.000102	0.000864	CcSEcCtD
Mefenamic acid—Urticaria—Dorzolamide—glaucoma	0.0001	0.000851	CcSEcCtD
Mefenamic acid—Salicylic acid—PTGS2—glaucoma	9.97e-05	0.0375	CrCbGaD
Mefenamic acid—Abdominal pain—Dorzolamide—glaucoma	9.96e-05	0.000847	CcSEcCtD
Mefenamic acid—Body temperature increased—Dorzolamide—glaucoma	9.96e-05	0.000847	CcSEcCtD
Mefenamic acid—Tension—Betaxolol—glaucoma	9.95e-05	0.000846	CcSEcCtD
Mefenamic acid—Abdominal pain—Travoprost—glaucoma	9.91e-05	0.000843	CcSEcCtD
Mefenamic acid—Agranulocytosis—Timolol—glaucoma	9.89e-05	0.000841	CcSEcCtD
Mefenamic acid—Anxiety—Clonidine—glaucoma	9.88e-05	0.00084	CcSEcCtD
Mefenamic acid—Asthenia—Acetazolamide—glaucoma	9.86e-05	0.000838	CcSEcCtD
Mefenamic acid—Dizziness—Bimatoprost—glaucoma	9.85e-05	0.000838	CcSEcCtD
Mefenamic acid—Nervousness—Betaxolol—glaucoma	9.85e-05	0.000837	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	9.85e-05	0.000837	CcSEcCtD
Mefenamic acid—Urticaria—Brinzolamide—glaucoma	9.84e-05	0.000836	CcSEcCtD
Mefenamic acid—Feeling abnormal—Pilocarpine—glaucoma	9.81e-05	0.000834	CcSEcCtD
Mefenamic acid—Discomfort—Clonidine—glaucoma	9.79e-05	0.000833	CcSEcCtD
Mefenamic acid—Vomiting—Apraclonidine—glaucoma	9.77e-05	0.000831	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Pilocarpine—glaucoma	9.73e-05	0.000828	CcSEcCtD
Mefenamic acid—Dry mouth—Clonidine—glaucoma	9.7e-05	0.000825	CcSEcCtD
Mefenamic acid—Dermatitis—Apraclonidine—glaucoma	9.68e-05	0.000823	CcSEcCtD
Mefenamic acid—Headache—Apraclonidine—glaucoma	9.62e-05	0.000818	CcSEcCtD
Mefenamic acid—Confusional state—Clonidine—glaucoma	9.58e-05	0.000815	CcSEcCtD
Mefenamic acid—Vision blurred—Betaxolol—glaucoma	9.55e-05	0.000812	CcSEcCtD
Mefenamic acid—Oedema—Clonidine—glaucoma	9.5e-05	0.000808	CcSEcCtD
Mefenamic acid—Tremor—Betaxolol—glaucoma	9.5e-05	0.000808	CcSEcCtD
Mefenamic acid—Hallucination—Timolol—glaucoma	9.47e-05	0.000805	CcSEcCtD
Mefenamic acid—Asthenia—Brimonidine—glaucoma	9.46e-05	0.000805	CcSEcCtD
Mefenamic acid—Infection—Clonidine—glaucoma	9.44e-05	0.000803	CcSEcCtD
Mefenamic acid—Abdominal pain—Pilocarpine—glaucoma	9.41e-05	0.0008	CcSEcCtD
Mefenamic acid—Body temperature increased—Pilocarpine—glaucoma	9.41e-05	0.0008	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Betaxolol—glaucoma	9.41e-05	0.0008	CcSEcCtD
Mefenamic acid—Diarrhoea—Acetazolamide—glaucoma	9.4e-05	0.000799	CcSEcCtD
Mefenamic acid—Rash—Bimatoprost—glaucoma	9.39e-05	0.000799	CcSEcCtD
Mefenamic acid—Dermatitis—Bimatoprost—glaucoma	9.38e-05	0.000798	CcSEcCtD
Mefenamic acid—Anaemia—Betaxolol—glaucoma	9.37e-05	0.000797	CcSEcCtD
Mefenamic acid—Shock—Clonidine—glaucoma	9.35e-05	0.000795	CcSEcCtD
Mefenamic acid—Pruritus—Brimonidine—glaucoma	9.33e-05	0.000793	CcSEcCtD
Mefenamic acid—Headache—Bimatoprost—glaucoma	9.33e-05	0.000793	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Clonidine—glaucoma	9.31e-05	0.000791	CcSEcCtD
Mefenamic acid—Tachycardia—Clonidine—glaucoma	9.28e-05	0.000789	CcSEcCtD
Mefenamic acid—Skin disorder—Clonidine—glaucoma	9.23e-05	0.000785	CcSEcCtD
Mefenamic acid—Malaise—Betaxolol—glaucoma	9.14e-05	0.000777	CcSEcCtD
Mefenamic acid—Nausea—Apraclonidine—glaucoma	9.12e-05	0.000776	CcSEcCtD
Mefenamic acid—Vertigo—Betaxolol—glaucoma	9.11e-05	0.000775	CcSEcCtD
Mefenamic acid—Syncope—Betaxolol—glaucoma	9.09e-05	0.000773	CcSEcCtD
Mefenamic acid—Dizziness—Acetazolamide—glaucoma	9.09e-05	0.000773	CcSEcCtD
Mefenamic acid—Anorexia—Clonidine—glaucoma	9.06e-05	0.00077	CcSEcCtD
Mefenamic acid—Asthenia—Dorzolamide—glaucoma	9.04e-05	0.000768	CcSEcCtD
Mefenamic acid—Asthenia—Travoprost—glaucoma	9e-05	0.000765	CcSEcCtD
Mefenamic acid—Palpitations—Betaxolol—glaucoma	8.96e-05	0.000762	CcSEcCtD
Mefenamic acid—Diclofenac—PTGS2—glaucoma	8.93e-05	0.0336	CrCbGaD
Mefenamic acid—Pruritus—Dorzolamide—glaucoma	8.91e-05	0.000758	CcSEcCtD
Mefenamic acid—Loss of consciousness—Betaxolol—glaucoma	8.91e-05	0.000758	CcSEcCtD
Mefenamic acid—Asthenia—Brinzolamide—glaucoma	8.88e-05	0.000755	CcSEcCtD
Mefenamic acid—Hypotension—Clonidine—glaucoma	8.88e-05	0.000755	CcSEcCtD
Mefenamic acid—Pruritus—Travoprost—glaucoma	8.87e-05	0.000754	CcSEcCtD
Mefenamic acid—Tinnitus—Timolol—glaucoma	8.87e-05	0.000754	CcSEcCtD
Mefenamic acid—Nausea—Bimatoprost—glaucoma	8.85e-05	0.000752	CcSEcCtD
Mefenamic acid—Pruritus—Brinzolamide—glaucoma	8.76e-05	0.000745	CcSEcCtD
Mefenamic acid—Flurbiprofen—PTGS2—glaucoma	8.74e-05	0.0329	CrCbGaD
Mefenamic acid—Vomiting—Acetazolamide—glaucoma	8.74e-05	0.000743	CcSEcCtD
Mefenamic acid—Dizziness—Brimonidine—glaucoma	8.72e-05	0.000742	CcSEcCtD
Mefenamic acid—Diarrhoea—Dorzolamide—glaucoma	8.62e-05	0.000733	CcSEcCtD
Mefenamic acid—Headache—Acetazolamide—glaucoma	8.61e-05	0.000732	CcSEcCtD
Mefenamic acid—Anxiety—Betaxolol—glaucoma	8.6e-05	0.000731	CcSEcCtD
Mefenamic acid—Insomnia—Clonidine—glaucoma	8.6e-05	0.000731	CcSEcCtD
Mefenamic acid—Diarrhoea—Travoprost—glaucoma	8.58e-05	0.00073	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	8.57e-05	0.000729	CcSEcCtD
Mefenamic acid—Asthenia—Pilocarpine—glaucoma	8.54e-05	0.000726	CcSEcCtD
Mefenamic acid—Paraesthesia—Clonidine—glaucoma	8.53e-05	0.000726	CcSEcCtD
Mefenamic acid—Discomfort—Betaxolol—glaucoma	8.53e-05	0.000725	CcSEcCtD
Mefenamic acid—Arrhythmia—Timolol—glaucoma	8.5e-05	0.000723	CcSEcCtD
Mefenamic acid—Dyspnoea—Clonidine—glaucoma	8.47e-05	0.000721	CcSEcCtD
Mefenamic acid—Diarrhoea—Brinzolamide—glaucoma	8.47e-05	0.00072	CcSEcCtD
Mefenamic acid—Somnolence—Clonidine—glaucoma	8.45e-05	0.000718	CcSEcCtD
Mefenamic acid—Dry mouth—Betaxolol—glaucoma	8.44e-05	0.000718	CcSEcCtD
Mefenamic acid—Pruritus—Pilocarpine—glaucoma	8.42e-05	0.000716	CcSEcCtD
Mefenamic acid—Alopecia—Timolol—glaucoma	8.41e-05	0.000715	CcSEcCtD
Mefenamic acid—Confusional state—Betaxolol—glaucoma	8.34e-05	0.000709	CcSEcCtD
Mefenamic acid—Mental disorder—Timolol—glaucoma	8.34e-05	0.000709	CcSEcCtD
Mefenamic acid—Dizziness—Dorzolamide—glaucoma	8.33e-05	0.000708	CcSEcCtD
Mefenamic acid—Rash—Brimonidine—glaucoma	8.32e-05	0.000707	CcSEcCtD
Mefenamic acid—Dermatitis—Brimonidine—glaucoma	8.31e-05	0.000706	CcSEcCtD
Mefenamic acid—Dizziness—Travoprost—glaucoma	8.29e-05	0.000705	CcSEcCtD
Mefenamic acid—Oedema—Betaxolol—glaucoma	8.27e-05	0.000704	CcSEcCtD
Mefenamic acid—Headache—Brimonidine—glaucoma	8.26e-05	0.000703	CcSEcCtD
Mefenamic acid—Decreased appetite—Clonidine—glaucoma	8.26e-05	0.000703	CcSEcCtD
Mefenamic acid—Infection—Betaxolol—glaucoma	8.22e-05	0.000699	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Clonidine—glaucoma	8.2e-05	0.000698	CcSEcCtD
Mefenamic acid—Dizziness—Brinzolamide—glaucoma	8.19e-05	0.000696	CcSEcCtD
Mefenamic acid—Nausea—Acetazolamide—glaucoma	8.16e-05	0.000694	CcSEcCtD
Mefenamic acid—Diarrhoea—Pilocarpine—glaucoma	8.14e-05	0.000692	CcSEcCtD
Mefenamic acid—Shock—Betaxolol—glaucoma	8.14e-05	0.000692	CcSEcCtD
Mefenamic acid—Tension—Timolol—glaucoma	8.13e-05	0.000691	CcSEcCtD
Mefenamic acid—Constipation—Clonidine—glaucoma	8.13e-05	0.000691	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Betaxolol—glaucoma	8.1e-05	0.000689	CcSEcCtD
Mefenamic acid—Tachycardia—Betaxolol—glaucoma	8.08e-05	0.000687	CcSEcCtD
Mefenamic acid—Nervousness—Timolol—glaucoma	8.04e-05	0.000684	CcSEcCtD
Mefenamic acid—Skin disorder—Betaxolol—glaucoma	8.04e-05	0.000683	CcSEcCtD
Mefenamic acid—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.02e-05	0.00208	CbGpPWpGaD
Mefenamic acid—Vomiting—Dorzolamide—glaucoma	8.01e-05	0.000681	CcSEcCtD
Mefenamic acid—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	7.99e-05	0.00207	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	7.98e-05	0.00207	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	7.97e-05	0.00207	CbGpPWpGaD
Mefenamic acid—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.95e-05	0.00206	CbGpPWpGaD
Mefenamic acid—Rash—Dorzolamide—glaucoma	7.94e-05	0.000675	CcSEcCtD
Mefenamic acid—Dermatitis—Dorzolamide—glaucoma	7.93e-05	0.000675	CcSEcCtD
Mefenamic acid—Ketoprofen—PTGS2—glaucoma	7.91e-05	0.0298	CrCbGaD
Mefenamic acid—Rash—Travoprost—glaucoma	7.91e-05	0.000672	CcSEcCtD
Mefenamic acid—Dermatitis—Travoprost—glaucoma	7.9e-05	0.000672	CcSEcCtD
Mefenamic acid—Headache—Dorzolamide—glaucoma	7.89e-05	0.000671	CcSEcCtD
Mefenamic acid—Anorexia—Betaxolol—glaucoma	7.89e-05	0.000671	CcSEcCtD
Mefenamic acid—Vomiting—Brinzolamide—glaucoma	7.87e-05	0.000669	CcSEcCtD
Mefenamic acid—Dizziness—Pilocarpine—glaucoma	7.87e-05	0.000669	CcSEcCtD
Mefenamic acid—Headache—Travoprost—glaucoma	7.86e-05	0.000668	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—PTGFR—glaucoma	7.84e-05	0.00203	CbGpPWpGaD
Mefenamic acid—Nausea—Brimonidine—glaucoma	7.83e-05	0.000666	CcSEcCtD
Mefenamic acid—Feeling abnormal—Clonidine—glaucoma	7.83e-05	0.000666	CcSEcCtD
Mefenamic acid—Rash—Brinzolamide—glaucoma	7.81e-05	0.000664	CcSEcCtD
Mefenamic acid—Vision blurred—Timolol—glaucoma	7.81e-05	0.000664	CcSEcCtD
Mefenamic acid—Dermatitis—Brinzolamide—glaucoma	7.8e-05	0.000663	CcSEcCtD
Mefenamic acid—AKR1C3—Disease—HEYL—glaucoma	7.77e-05	0.00202	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—FGFR1OP—glaucoma	7.77e-05	0.00202	CbGpPWpGaD
Mefenamic acid—Gastrointestinal pain—Clonidine—glaucoma	7.77e-05	0.000661	CcSEcCtD
Mefenamic acid—Headache—Brinzolamide—glaucoma	7.76e-05	0.00066	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.75e-05	0.00201	CbGpPWpGaD
Mefenamic acid—Hypotension—Betaxolol—glaucoma	7.73e-05	0.000657	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.68e-05	0.00199	CbGpPWpGaD
Mefenamic acid—Angioedema—Timolol—glaucoma	7.57e-05	0.000644	CcSEcCtD
Mefenamic acid—Vomiting—Pilocarpine—glaucoma	7.57e-05	0.000643	CcSEcCtD
Mefenamic acid—Urticaria—Clonidine—glaucoma	7.55e-05	0.000642	CcSEcCtD
Mefenamic acid—Abdominal pain—Clonidine—glaucoma	7.51e-05	0.000639	CcSEcCtD
Mefenamic acid—Body temperature increased—Clonidine—glaucoma	7.51e-05	0.000639	CcSEcCtD
Mefenamic acid—Rash—Pilocarpine—glaucoma	7.5e-05	0.000638	CcSEcCtD
Mefenamic acid—Dermatitis—Pilocarpine—glaucoma	7.5e-05	0.000638	CcSEcCtD
Mefenamic acid—Insomnia—Betaxolol—glaucoma	7.48e-05	0.000636	CcSEcCtD
Mefenamic acid—Nausea—Dorzolamide—glaucoma	7.48e-05	0.000636	CcSEcCtD
Mefenamic acid—Headache—Pilocarpine—glaucoma	7.46e-05	0.000634	CcSEcCtD
Mefenamic acid—Nausea—Travoprost—glaucoma	7.45e-05	0.000633	CcSEcCtD
Mefenamic acid—Vertigo—Timolol—glaucoma	7.44e-05	0.000633	CcSEcCtD
Mefenamic acid—Paraesthesia—Betaxolol—glaucoma	7.43e-05	0.000632	CcSEcCtD
Mefenamic acid—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	7.43e-05	0.00193	CbGpPWpGaD
Mefenamic acid—Syncope—Timolol—glaucoma	7.43e-05	0.000632	CcSEcCtD
Mefenamic acid—Dyspnoea—Betaxolol—glaucoma	7.38e-05	0.000627	CcSEcCtD
Mefenamic acid—Nausea—Brinzolamide—glaucoma	7.35e-05	0.000625	CcSEcCtD
Mefenamic acid—Palpitations—Timolol—glaucoma	7.32e-05	0.000622	CcSEcCtD
Mefenamic acid—Dyspepsia—Betaxolol—glaucoma	7.28e-05	0.000619	CcSEcCtD
Mefenamic acid—Loss of consciousness—Timolol—glaucoma	7.28e-05	0.000619	CcSEcCtD
Mefenamic acid—AKR1C1—Disease—HDAC9—glaucoma	7.21e-05	0.00187	CbGpPWpGaD
Mefenamic acid—Decreased appetite—Betaxolol—glaucoma	7.19e-05	0.000612	CcSEcCtD
Mefenamic acid—Hypertension—Timolol—glaucoma	7.15e-05	0.000608	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Betaxolol—glaucoma	7.14e-05	0.000607	CcSEcCtD
Mefenamic acid—Constipation—Betaxolol—glaucoma	7.08e-05	0.000602	CcSEcCtD
Mefenamic acid—Nausea—Pilocarpine—glaucoma	7.07e-05	0.000601	CcSEcCtD
Mefenamic acid—Anxiety—Timolol—glaucoma	7.03e-05	0.000598	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	7e-05	0.000595	CcSEcCtD
Mefenamic acid—Discomfort—Timolol—glaucoma	6.97e-05	0.000592	CcSEcCtD
Mefenamic acid—Dry mouth—Timolol—glaucoma	6.9e-05	0.000586	CcSEcCtD
Mefenamic acid—Asthenia—Clonidine—glaucoma	6.82e-05	0.00058	CcSEcCtD
Mefenamic acid—Feeling abnormal—Betaxolol—glaucoma	6.82e-05	0.00058	CcSEcCtD
Mefenamic acid—PTGS2—Spinal Cord Injury—NGFR—glaucoma	6.82e-05	0.00177	CbGpPWpGaD
Mefenamic acid—Confusional state—Timolol—glaucoma	6.82e-05	0.00058	CcSEcCtD
Mefenamic acid—Oedema—Timolol—glaucoma	6.76e-05	0.000575	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Timolol—glaucoma	6.76e-05	0.000575	CcSEcCtD
Mefenamic acid—Pruritus—Clonidine—glaucoma	6.72e-05	0.000572	CcSEcCtD
Mefenamic acid—Infection—Timolol—glaucoma	6.72e-05	0.000571	CcSEcCtD
Mefenamic acid—Shock—Timolol—glaucoma	6.65e-05	0.000566	CcSEcCtD
Mefenamic acid—PTGS1—Biological oxidations—CYP1B1—glaucoma	6.6e-05	0.00171	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GSTT1—glaucoma	6.59e-05	0.00171	CbGpPWpGaD
Mefenamic acid—Urticaria—Betaxolol—glaucoma	6.57e-05	0.000559	CcSEcCtD
Mefenamic acid—Skin disorder—Timolol—glaucoma	6.57e-05	0.000558	CcSEcCtD
Mefenamic acid—Body temperature increased—Betaxolol—glaucoma	6.54e-05	0.000556	CcSEcCtD
Mefenamic acid—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.53e-05	0.00169	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CA1—glaucoma	6.51e-05	0.00169	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Clonidine—glaucoma	6.5e-05	0.000553	CcSEcCtD
Mefenamic acid—Anorexia—Timolol—glaucoma	6.44e-05	0.000548	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	6.42e-05	0.00167	CbGpPWpGaD
Mefenamic acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	6.38e-05	0.00166	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	6.33e-05	0.00164	CbGpPWpGaD
Mefenamic acid—Hypotension—Timolol—glaucoma	6.32e-05	0.000537	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism—CTSA—glaucoma	6.31e-05	0.00164	CbGpPWpGaD
Mefenamic acid—Dizziness—Clonidine—glaucoma	6.28e-05	0.000534	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—TXN—glaucoma	6.24e-05	0.00162	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.16e-05	0.0016	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—RPTOR—glaucoma	6.13e-05	0.00159	CbGpPWpGaD
Mefenamic acid—Insomnia—Timolol—glaucoma	6.11e-05	0.00052	CcSEcCtD
Mefenamic acid—Paraesthesia—Timolol—glaucoma	6.07e-05	0.000516	CcSEcCtD
Mefenamic acid—Vomiting—Clonidine—glaucoma	6.04e-05	0.000514	CcSEcCtD
Mefenamic acid—Dyspnoea—Timolol—glaucoma	6.03e-05	0.000512	CcSEcCtD
Mefenamic acid—Somnolence—Timolol—glaucoma	6.01e-05	0.000511	CcSEcCtD
Mefenamic acid—Rash—Clonidine—glaucoma	5.99e-05	0.00051	CcSEcCtD
Mefenamic acid—Dermatitis—Clonidine—glaucoma	5.99e-05	0.000509	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism—CA2—glaucoma	5.96e-05	0.00154	CbGpPWpGaD
Mefenamic acid—Headache—Clonidine—glaucoma	5.95e-05	0.000506	CcSEcCtD
Mefenamic acid—Dyspepsia—Timolol—glaucoma	5.95e-05	0.000506	CcSEcCtD
Mefenamic acid—AKR1C1—Signaling Pathways—NCK2—glaucoma	5.94e-05	0.00154	CbGpPWpGaD
Mefenamic acid—Asthenia—Betaxolol—glaucoma	5.94e-05	0.000505	CcSEcCtD
Mefenamic acid—PTGS2—Spinal Cord Injury—BDNF—glaucoma	5.93e-05	0.00154	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	5.91e-05	0.00153	CbGpPWpGaD
Mefenamic acid—Decreased appetite—Timolol—glaucoma	5.88e-05	0.0005	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—OPN4—glaucoma	5.86e-05	0.00152	CbGpPWpGaD
Mefenamic acid—Pruritus—Betaxolol—glaucoma	5.85e-05	0.000498	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Timolol—glaucoma	5.84e-05	0.000496	CcSEcCtD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.82e-05	0.00151	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.82e-05	0.00151	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NARFL—glaucoma	5.8e-05	0.0015	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CA5A—glaucoma	5.8e-05	0.0015	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—IL1A—glaucoma	5.69e-05	0.00148	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.69e-05	0.00148	CbGpPWpGaD
Mefenamic acid—Diarrhoea—Betaxolol—glaucoma	5.66e-05	0.000481	CcSEcCtD
Mefenamic acid—Nausea—Clonidine—glaucoma	5.65e-05	0.00048	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.64e-05	0.00146	CbGpPWpGaD
Mefenamic acid—Feeling abnormal—Timolol—glaucoma	5.57e-05	0.000474	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Timolol—glaucoma	5.53e-05	0.00047	CcSEcCtD
Mefenamic acid—Dizziness—Betaxolol—glaucoma	5.47e-05	0.000465	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—HEYL—glaucoma	5.44e-05	0.00141	CbGpPWpGaD
Mefenamic acid—Urticaria—Timolol—glaucoma	5.37e-05	0.000457	CcSEcCtD
Mefenamic acid—CYP2C8—Biological oxidations—GSTT1—glaucoma	5.35e-05	0.00139	CbGpPWpGaD
Mefenamic acid—Abdominal pain—Timolol—glaucoma	5.34e-05	0.000454	CcSEcCtD
Mefenamic acid—Body temperature increased—Timolol—glaucoma	5.34e-05	0.000454	CcSEcCtD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	5.34e-05	0.00138	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.31e-05	0.00138	CbGpPWpGaD
Mefenamic acid—PTGS1—Biological oxidations—GSTM1—glaucoma	5.27e-05	0.00137	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PTGFR—glaucoma	5.27e-05	0.00137	CbGpPWpGaD
Mefenamic acid—Vomiting—Betaxolol—glaucoma	5.26e-05	0.000447	CcSEcCtD
Mefenamic acid—AKR1C2—Metabolism—CYP1B1—glaucoma	5.25e-05	0.00136	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—ABCA1—glaucoma	5.25e-05	0.00136	CbGpPWpGaD
Mefenamic acid—Rash—Betaxolol—glaucoma	5.22e-05	0.000444	CcSEcCtD
Mefenamic acid—Dermatitis—Betaxolol—glaucoma	5.21e-05	0.000443	CcSEcCtD
Mefenamic acid—Headache—Betaxolol—glaucoma	5.18e-05	0.000441	CcSEcCtD
Mefenamic acid—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	5.16e-05	0.00134	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	5.08e-05	0.00132	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—HDAC9—glaucoma	5.05e-05	0.00131	CbGpPWpGaD
Mefenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	5.02e-05	0.0013	CbGpPWpGaD
Mefenamic acid—Nausea—Betaxolol—glaucoma	4.91e-05	0.000418	CcSEcCtD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.89e-05	0.00127	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—HDAC9—glaucoma	4.85e-05	0.00126	CbGpPWpGaD
Mefenamic acid—Asthenia—Timolol—glaucoma	4.85e-05	0.000412	CcSEcCtD
Mefenamic acid—AKR1C1—Metabolism—GSTT1—glaucoma	4.83e-05	0.00125	CbGpPWpGaD
Mefenamic acid—Pruritus—Timolol—glaucoma	4.78e-05	0.000407	CcSEcCtD
Mefenamic acid—Diarrhoea—Timolol—glaucoma	4.62e-05	0.000393	CcSEcCtD
Mefenamic acid—PTGS2—Metabolism—CA5A—glaucoma	4.61e-05	0.00119	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NARFL—glaucoma	4.61e-05	0.00119	CbGpPWpGaD
Mefenamic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	4.58e-05	0.00119	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	4.48e-05	0.00116	CbGpPWpGaD
Mefenamic acid—Dizziness—Timolol—glaucoma	4.47e-05	0.00038	CcSEcCtD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.41e-05	0.00114	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—GSTT1—glaucoma	4.35e-05	0.00113	CbGpPWpGaD
Mefenamic acid—Vomiting—Timolol—glaucoma	4.3e-05	0.000365	CcSEcCtD
Mefenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	4.28e-05	0.00111	CbGpPWpGaD
Mefenamic acid—Rash—Timolol—glaucoma	4.26e-05	0.000362	CcSEcCtD
Mefenamic acid—CYP2C8—Biological oxidations—CYP1B1—glaucoma	4.26e-05	0.00111	CbGpPWpGaD
Mefenamic acid—Dermatitis—Timolol—glaucoma	4.26e-05	0.000362	CcSEcCtD
Mefenamic acid—Headache—Timolol—glaucoma	4.23e-05	0.00036	CcSEcCtD
Mefenamic acid—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	4.2e-05	0.00109	CbGpPWpGaD
Mefenamic acid—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	4.2e-05	0.00109	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—TXN—glaucoma	4.2e-05	0.00109	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—GSTM1—glaucoma	4.2e-05	0.00109	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LRP12—glaucoma	4.17e-05	0.00108	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—RPTOR—glaucoma	4.13e-05	0.00107	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	4.06e-05	0.00105	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	4.03e-05	0.00105	CbGpPWpGaD
Mefenamic acid—Nausea—Timolol—glaucoma	4.01e-05	0.000341	CcSEcCtD
Mefenamic acid—AKR1C3—Signaling Pathways—NCK2—glaucoma	4e-05	0.00104	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.98e-05	0.00103	CbGpPWpGaD
Mefenamic acid—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	3.97e-05	0.00103	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—SMO—glaucoma	3.95e-05	0.00102	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.9e-05	0.00101	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CDKN2B—glaucoma	3.88e-05	0.00101	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—ABCA1—glaucoma	3.85e-05	0.000999	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CYP1B1—glaucoma	3.85e-05	0.000999	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.83e-05	0.000993	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.79e-05	0.000984	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CA5A—glaucoma	3.75e-05	0.000972	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NARFL—glaucoma	3.75e-05	0.000972	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—MTHFR—glaucoma	3.71e-05	0.000962	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NTRK2—glaucoma	3.61e-05	0.000937	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.47e-05	0.000899	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—APOE—glaucoma	3.45e-05	0.000895	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.45e-05	0.000895	CbGpPWpGaD
Mefenamic acid—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	3.43e-05	0.00089	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.42e-05	0.000887	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—CAV1—glaucoma	3.42e-05	0.000887	CbGpPWpGaD
Mefenamic acid—CYP2C8—Biological oxidations—GSTM1—glaucoma	3.41e-05	0.000883	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—HDAC9—glaucoma	3.4e-05	0.000881	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	3.36e-05	0.000871	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GSTT1—glaucoma	3.25e-05	0.000844	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—MTHFR—glaucoma	3.25e-05	0.000843	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.24e-05	0.00084	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NGFR—glaucoma	3.1e-05	0.000804	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—GSTM1—glaucoma	3.08e-05	0.000799	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NARFL—glaucoma	3.05e-05	0.000791	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA5A—glaucoma	3.05e-05	0.000791	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—APOE—glaucoma	3.03e-05	0.000785	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	3.02e-05	0.000784	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CAV1—glaucoma	3e-05	0.000777	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.95e-05	0.000765	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NTRK1—glaucoma	2.95e-05	0.000764	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CA1—glaucoma	2.83e-05	0.000735	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—BAD—glaucoma	2.82e-05	0.000731	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—MMP9—glaucoma	2.8e-05	0.000726	CbGpPWpGaD
Mefenamic acid—CYP2C9—Biological oxidations—GSTM1—glaucoma	2.77e-05	0.000719	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CTSA—glaucoma	2.74e-05	0.000712	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.73e-05	0.000709	CbGpPWpGaD
Mefenamic acid—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	2.72e-05	0.000706	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—MTHFR—glaucoma	2.72e-05	0.000706	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN2B—glaucoma	2.71e-05	0.000704	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—FGFR1OP—glaucoma	2.69e-05	0.000697	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HEYL—glaucoma	2.69e-05	0.000697	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SMO—glaucoma	2.66e-05	0.000689	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.62e-05	0.00068	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN2B—glaucoma	2.61e-05	0.000676	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—EDN1—glaucoma	2.61e-05	0.000675	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CYP1B1—glaucoma	2.59e-05	0.000672	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ABCA1—glaucoma	2.59e-05	0.000672	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CA2—glaucoma	2.59e-05	0.000672	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—NOS3—glaucoma	2.59e-05	0.000671	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—APOE—glaucoma	2.53e-05	0.000657	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.53e-05	0.000657	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.53e-05	0.000657	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—CAV1—glaucoma	2.51e-05	0.000651	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NTRK2—glaucoma	2.43e-05	0.000631	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NGF—glaucoma	2.39e-05	0.000621	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—PTGS2—glaucoma	2.37e-05	0.000613	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—C3—glaucoma	2.28e-05	0.00059	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—NOS3—glaucoma	2.27e-05	0.000588	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CA1—glaucoma	2.25e-05	0.000583	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MTHFR—glaucoma	2.19e-05	0.000567	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CTSA—glaucoma	2.18e-05	0.000565	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TNF—glaucoma	2.15e-05	0.000559	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—APOE—glaucoma	2.12e-05	0.000549	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CAV1—glaucoma	2.1e-05	0.000544	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NGFR—glaucoma	2.09e-05	0.000541	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—PTGS2—glaucoma	2.07e-05	0.000538	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—GSTM1—glaucoma	2.07e-05	0.000537	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CA2—glaucoma	2.06e-05	0.000534	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.06e-05	0.000533	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—APOE—glaucoma	2.04e-05	0.000528	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CAV1—glaucoma	2.02e-05	0.000523	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.01e-05	0.000522	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.01e-05	0.000522	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—FN1—glaucoma	2e-05	0.000518	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NTRK1—glaucoma	1.98e-05	0.000514	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—BAD—glaucoma	1.97e-05	0.000512	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—CDKN1B—glaucoma	1.96e-05	0.000509	CbGpPWpGaD
Mefenamic acid—PTGS2—Spinal Cord Injury—TP53—glaucoma	1.9e-05	0.000492	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—NOS3—glaucoma	1.9e-05	0.000492	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—BAD—glaucoma	1.9e-05	0.000492	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—MTHFR—glaucoma	1.83e-05	0.000475	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CA1—glaucoma	1.83e-05	0.000475	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN2B—glaucoma	1.83e-05	0.000474	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—TXN—glaucoma	1.83e-05	0.000474	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CTSA—glaucoma	1.77e-05	0.00046	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—EDN1—glaucoma	1.75e-05	0.000455	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—PTGS2—glaucoma	1.74e-05	0.00045	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.71e-05	0.000443	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—APOE—glaucoma	1.71e-05	0.000442	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—CAV1—glaucoma	1.69e-05	0.000438	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HDAC9—glaucoma	1.68e-05	0.000435	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CA2—glaucoma	1.67e-05	0.000434	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.67e-05	0.000432	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.65e-05	0.000428	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.64e-05	0.000424	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.64e-05	0.000424	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NGF—glaucoma	1.61e-05	0.000418	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NOS3—glaucoma	1.59e-05	0.000412	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—C3—glaucoma	1.53e-05	0.000397	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—NOS3—glaucoma	1.53e-05	0.000395	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA1—glaucoma	1.49e-05	0.000386	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.47e-05	0.00038	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—TXN—glaucoma	1.45e-05	0.000376	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CTSA—glaucoma	1.44e-05	0.000374	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APOE—glaucoma	1.43e-05	0.00037	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTT1—glaucoma	1.42e-05	0.000367	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CAV1—glaucoma	1.41e-05	0.000366	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—glaucoma	1.39e-05	0.000362	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CDKN1B—glaucoma	1.37e-05	0.000357	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CA2—glaucoma	1.36e-05	0.000353	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—FN1—glaucoma	1.34e-05	0.000349	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.33e-05	0.000345	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.33e-05	0.000345	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—BAD—glaucoma	1.33e-05	0.000344	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.32e-05	0.000343	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—CDKN1B—glaucoma	1.32e-05	0.000343	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.31e-05	0.00034	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.29e-05	0.000335	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NOS3—glaucoma	1.28e-05	0.000331	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—glaucoma	1.27e-05	0.00033	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—TXN—glaucoma	1.18e-05	0.000306	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—glaucoma	1.17e-05	0.000303	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—glaucoma	1.14e-05	0.000297	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.14e-05	0.000296	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CYP1B1—glaucoma	1.13e-05	0.000293	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ABCA1—glaucoma	1.13e-05	0.000293	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTT1—glaucoma	1.12e-05	0.000291	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.08e-05	0.000279	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOS3—glaucoma	1.07e-05	0.000277	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.07e-05	0.000277	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—TXN—glaucoma	9.6e-06	0.000249	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CDKN1B—glaucoma	9.25e-06	0.00024	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTT1—glaucoma	9.15e-06	0.000237	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTM1—glaucoma	9.02e-06	0.000234	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN2B—glaucoma	9.01e-06	0.000234	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CYP1B1—glaucoma	8.96e-06	0.000232	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ABCA1—glaucoma	8.96e-06	0.000232	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.76e-06	0.000227	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.68e-06	0.000225	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TP53—glaucoma	8.64e-06	0.000224	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—glaucoma	8.57e-06	0.000222	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MTHFR—glaucoma	7.97e-06	0.000207	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—glaucoma	7.69e-06	0.0002	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTHFR—glaucoma	7.56e-06	0.000196	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTT1—glaucoma	7.44e-06	0.000193	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOE—glaucoma	7.42e-06	0.000192	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.38e-06	0.000191	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CAV1—glaucoma	7.35e-06	0.000191	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ABCA1—glaucoma	7.29e-06	0.000189	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP1B1—glaucoma	7.29e-06	0.000189	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTM1—glaucoma	7.16e-06	0.000186	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOE—glaucoma	7.03e-06	0.000182	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CAV1—glaucoma	6.97e-06	0.000181	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—BAD—glaucoma	6.56e-06	0.00017	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MTHFR—glaucoma	6.33e-06	0.000164	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6e-06	0.000156	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP1B1—glaucoma	5.93e-06	0.000154	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCA1—glaucoma	5.93e-06	0.000154	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOE—glaucoma	5.89e-06	0.000153	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CAV1—glaucoma	5.84e-06	0.000151	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTM1—glaucoma	5.83e-06	0.000151	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TP53—glaucoma	5.81e-06	0.000151	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NOS3—glaucoma	5.56e-06	0.000144	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS3—glaucoma	5.27e-06	0.000137	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MTHFR—glaucoma	5.15e-06	0.000134	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—glaucoma	5.09e-06	0.000132	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOE—glaucoma	4.79e-06	0.000124	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CAV1—glaucoma	4.75e-06	0.000123	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTM1—glaucoma	4.74e-06	0.000123	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CDKN1B—glaucoma	4.57e-06	0.000118	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NOS3—glaucoma	4.41e-06	0.000114	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MTHFR—glaucoma	4.19e-06	0.000109	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOE—glaucoma	3.9e-06	0.000101	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CAV1—glaucoma	3.87e-06	0.0001	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NOS3—glaucoma	3.59e-06	9.31e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—glaucoma	3.28e-06	8.52e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NOS3—glaucoma	2.92e-06	7.58e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—glaucoma	2.67e-06	6.93e-05	CbGpPWpGaD
